Previous study has shown that miR-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression by downregulating CCNE 1 in breast cancer, resulting in reduced cytokine expression in vitro, cell invasion, and cell proliferation in vitro [60]. This evidence concerns the gene NFKB1 and breast carcinoma.